Research Article

Effects of Qili Qiangxin Capsule on AQP2, V2R, and AT1R in Rats with Chronic Heart Failure

Figure 8

QL reduces the levels of plasma AVP and renal V2R protein expression in CHF rats. (a) AVP levels in plasma were elevated in CHF rats; treatment with QL decreased AVP levels in plasma; however treatment with Valsartan had no effect on plasma AVP in CHF rats. (b) Renal V2R protein increased in CHF rats; treatment with QL significantly attenuated renal V2R protein in CHF rats. (, versus the CHF group, , versus the sham group).